Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.7 USD | -0.89% | -3.82% | +11.35% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.35% | 6.43B | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.19% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Earnings Flash (BPMC) BLUEPRINT MEDICINES CORPORATION Posts Q1 Revenue $96.1M, vs. Street Est of $81.4M